Acute Pancreatitis: Assessment of Severity with Clinical and CT Evaluation

Treatment of patients with acute pancreatitis is based on the initial assessment of disease severity. Severe pancreatitis occurs in 20%–30% of all patients with acute pancreatitis and is characterized by a protracted clinical course, multiorgan failure, and pancreatic necrosis. Early staging is based on the presence and degree of systemic failure (cardiovascular, pulmonary, renal) and on the presence and extent of pancreatic necrosis. Individual laboratory indexes (markers of pancreatic injury, markers of inflammatory response), while promising, have not yet gained clinical acceptance. Numeric grading systems with sensitivities of about 70% are commonly used today as indicators of organ failure and disease severity. Contrast material–enhanced computed tomography is used in addition to help evaluate local pancreatic morphology and the presence and extent of pancreatic necrosis. Advantages and limitations of the clinical, laboratory, and imaging prognostic indexes are analyzed and discussed.

© RSNA, 2002

References

  • 1 Bradley EL, III. A clinically based classification system for acute pancreatitis. Arch Surg 1993; 128:586-590.
  • 2 Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Int J Pancreatol 1999; 25:195-210.
  • 3 Berk JE. The management of acute pancreatitis: a critical assessment as Dr. Bockus would have wished. Am J Gastroenterol 1995; 90:696-703.
  • 4 Malfertheiner P, Dominguez-Munoz JE. Prognostic factors in acute pancreatitis. Int J Pancreatol 1993; 14:1-8.
  • 5 Banks PA. Acute pancreatitis: medical and surgical management. Am J Gastroenterol 1994; 89:S78-S85.
  • 6 Banks PA. Practice guidelines in acute pancreatitis. Am J Gastroenterol 1997; 92:377-386.
  • 7 Agarwal N, Pitchumoni CS. Assessment of severity in acute pancreatitis. Am J Gastroenterol 1991; 86:1385-1391.
  • 8 Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World J Surg 1997; 21:130-135.
  • 9 Banks PA. A new classification system for acute pancreatitis. Am J Gastroenterol 1994; 89:151-152.
  • 10 Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984; 25:756-759.
  • 11 Singer MV, Gyr K, Sarles H. Revised classification of pancreatitis. Gastroenterology 1985; 89:683-690.
  • 12 Sarles H, Adler G, Dani R, et al. The pancreatitis classification of Marseille: Rome, 1988. Scand J Gastroenterol 1989; 24:651-652.
  • 13 Sarles H. Definitions and classification of pancreatitis. Pancreas 1991; 6:470-474.
  • 14 Kloppel G. Pathology of severe acute pancreatitis. In: Bradley EL, III, eds. Acute pancreatitis: diagnosis and therapy. New York, NY: Raven, 1994; 35-46.
  • 15 Sakorafas GH, Tsiotos GG, Bower TC, Sarr MG. Ischemic necrotizing pancreatitis. Int J Pancreatol 1998; 24:117-121.
  • 16 Fernandez-del Castillo C, Harringer W, Warshaw AL, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325:382-387.
  • 17 Warshaw AL, O’Hara PJ. Susceptibility of the pancreas to ischemic injury in shock. Ann Surg 1978; 188:197-201.
  • 18 Fernandez-Cruz L, Sabater L, Gilbert R, Ricart MG, Saenz A, Astudillo E. Native and graft pancreatitis following combined pancreas-renal transplantation. Br J Surg 1993; 80:1429-1432.
  • 19 Freeny PC. Incremental dynamic bolus computed tomography of acute pancreatitis. Int J Pancreatol 1993; 13:147-158.
  • 20 Uhl W, Buchler M, Malfertheiner P, Isenmann R, Martini M, Beger HG. Pancreatic necrosis develops within four days after the acute attack (abstr). Gastroenterology 1991; 100(5 pt 2):A302.
  • 21 Heath D, Wilson C, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1994; 35:1311-1315.
  • 22 Puolakkainen P, Valtonen V, Paananen A, Schroder T. C-reactive protein (CRP) and serum phospholipase A in the assessment of the severity of acute pancreatitis. Gut 1987; 28:764-771.
  • 23 Uhl W, Buchler M, Malfertheiner P, Martini M, Beger HG. PMN-elastase in comparison with CRP, antiproteases and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6:253-259.
  • 24 Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, anti-proteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76:177-181.
  • 25 Gross V, Leser HG, Heinisch A, Scholmerich J. Inflammatory mediators and cytokines: new aspects of the pathophysiology and assessment of severity of acute pancreatitis. Hepatogastroenterology 1993; 40:522-531.
  • 26 Tenner S, Fernandez-del Castillo C, Warshaw A, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997; 21:105-110.
  • 27 Denham W, Norman J. The potential role of therapeutic cytokine manipulation in acute pancreatitis. Surg Clin North Am 1999; 79:767-781.
  • 28 Renner IG, Savage WT, Pantoia JL, Renner VJ. Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985; 30:1005-1018.
  • 29 Lankisch PG, Schirren CA. Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis. Pancreas 1990; 5:626-629.
  • 30 Porter KA, Banks PA. Obesity as a predictor of severity in acute pancreatitis. Int J Pancreatol 1991; 10:247-252.
  • 31 Funnell IC, Bornman PC, Weakley SP, Terblanche J, Marks IN. Obesity: an important prognostic factor in acute pancreatitis. Br J Surg 1993; 80:484-486.
  • 32 Dickson AP, Imrie CW. The incidence and prognosis of body wall ecchymosis in acute pancreatitis. Surg Gynaecol Obstet 1984; 159:343-347.
  • 33 McMahon MJ, Playforth MJ, Pickforth IR. A comparative study of methods for the prediction of severity of attacks of acute pancreatitis. Br J Surg 1980; 67:22-25.
  • 34 Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77:1260-1264.
  • 35 Corfield AP, Cooper MJ, Williamson RCN, et al. Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet 1985; 2:403-407.
  • 36 Sainio V, Puolakkainen P, Kempainnen E, et al. Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis. Scand J Gastroenterol 1996; 31:818-824.
  • 37 Lankisch PG, Schirren CA, Otto J. Methemalbumin in acute pancreatitis: an evaluation of its prognostic value and comparison with multiple prognostic parameters. Am J Gastroenterol 1989; 84:1391-1395.
  • 38 Warshaw AL, Lee KH. Serum ribonuclease elevations and pancreatic necrosis in acute pancreatitis. Surgery 1979; 86:227-234.
  • 39 Kemmer TP, Malfertheiner P, Buchler M, Kemmer ML, Ditschuneit H. Serum ribonuclease activity in the diagnosis of pancreatic disease. Int J Pancreatol 1991; 8:23-33.
  • 40 Exley AR, Leese T, Holliday MP, et al. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992; 33:1126-1128.
  • 41 Paajainen H, Laato M, Jaakkola M, Pulkki A, Niinikoski J, Nordback I. Serum tumour necrosis factor compared with C-reactive protein in the assessment of severity of acute pancreatitis. Br J Surg 1995; 82:271-273.
  • 42 de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KHC. Serum concentration of inflammatory mediators related to organ failure with acute pancreatitis. Br J Surg 1996; 83:349-353.
  • 43 Nevalainen TJ. The role of phospholipase A in acute pancreatitis. Scand J Gastroenterol 1980; 15:641-650.
  • 44 Buchler M, Malfertheiner P, Schadlich H, Nevalainen TJ, Freiss H, Beger HG. Role of phospholipase A2 in human acute pancreatitis. Gastroenterology 1989; 97:1521-1526.
  • 45 Bird NC, Goodman AJ, Johnson AG. Serum phospholipase A2 activity in acute pancreatitis: an early guide to severity. Br J Surg 1989; 76:731-732.
  • 46 Dominguez-Munoz JE, Caraballo F, Garcia MJ. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br J Surg 1991; 78:1230-1234.
  • 47 Mayer AD, McMahon MJ, Bowen M, Cooper EH. C-reactive protein: an aid to assessment and monitoring acute pancreatitis. J Clin Pathol 1984; 37:207-211.
  • 48 Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, anti-proteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76:177-181.
  • 49 Mayer AD, McMahon MJ, Corfield AP, et al. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. N Engl J Med 1985; 312:399-404.
  • 50 Bank S, Wise L, Gersten M. Risk factors in acute pancreatitis. Am J Gastroenterol 1983; 78:637-640.
  • 51 Ranson JHC, Rifkind KM, Roses DF, et al. Objective early identification of severe acute pancreatitis. Am J Gastroenterol 1974; 61:443-451.
  • 52 Blamey SL, Imrie CW, O’Neil J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut 1984; 25:1340-1346.
  • 53 Agarwal N, Pitchumoni CS. Simplified prognostic criteria in acute pancreatitis. Pancreas 1986; 1:69-73.
  • 54 Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829.
  • 55 Larvin M, McMahon MJ. APACHE II score for assessment and monitoring of acute pancreatitis. Lancet 1989; 2:201-204.
  • 56 Wilson C, Health DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE-II clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77:1260-1264.
  • 57 Talamini G, Bassi C, Falconi M, et al. Risk of death from acute pancreatitis. Int J Pancreatol 1996; 19:15-24.
  • 58 Pezzilli R, Billi P, Baraket P. Peripheral leukocyte count and chest x-ray in the early assessment of the severity of acute pancreatitis. Digestion 1996; 57:25-32.
  • 59 Talamini G, Uomo G, Pezzilli R, et al. Renal function and chest x-rays in the assessment of 539 acute pancreatitis patients (abstr). Gut 1997; 41(suppl 3):A136.
  • 60 Finley JW. Respiratory complications of acute pancreatitis. Am Surg 1969; 35:591-598.
  • 61 Millward SE, Breatnach E, Simpkins KC, McMahon MJ. Do plain films of the chest and abdomen have a role in the diagnosis of acute pancreatitis? Clin Radiol 1983; 34:133-137.
  • 62 Jeffrey RB. Sonography in acute pancreatitis. Radiol Clin North Am 1989; 27:5-17.
  • 63 Jeffrey RB, Laing FC. Wing VW. Extrapancreatic spread of acute pancreatitis: new observations with real-time ultrasound. Radiology 1986; 159:707-711.
  • 64 Mendez G, Jr, Isikoff MB, Hill MC. CT of acute pancreatitis: interim assessment. AJR Am J Roentgenol 1980; 135:463-469.
  • 65 Hill MC, Barkin J, Isikoff MB, Silverstein W, Kaiser M. Acute pancreatitis: clinical vs. CT findings. AJR Am J Roentgenol 1982; 139:263-269.
  • 66 Nordestgaard AG, Wilson SE, Williams RA. Early computerized tomography as a predictor of outcome in acute pancreatitis. Am J Surg 1986; 152:127-132.
  • 67 Balthazar EJ, Ranson JHC, Naidich DP, Megibow AJ, Caccavale R, Cooper MM. Acute pancreatitis: prognostic value of CT. Radiology 1985; 156:767-772.
  • 68 Clavien PA, Hauser H, Meyer P, Rohner A. Value of contrast-enhanced computerized tomography in the early diagnosis and prognosis of acute pancreatitis. Am J Surg 1988; 155:457-466.
  • 69 London NJM, Neoptolemos JP, Lavelle J, Bailey I, James D. Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: a prospective study. Br J Surg 1989; 76:268-272.
  • 70 Kivisaari L, Somer K, Standertskjold-Nordenstam CG, Schroder T, Kivilaakso E, Lempinen M. Early detection of acute fulminant pancreatitis by contrast enhanced computed tomography. Scand J Gastroenterol 1983; 18:39-41.
  • 71 Beger HG, Maier W, Block S, Buchler M. How do imaging methods influence the surgical strategy in acute pancreatitis? In: Malfertheiner P, Ditschuneit H, eds Diagnostic procedures in pancreatic disease. Berlin, Germany: Springer-Verlag, 1986; 54-60.
  • 72 Maier W. Early objective diagnosis and staging of acute pancreatitis by contrast enhanced CT. In: Beger H, Buchler M, eds. Acute pancreatitis. Berlin, Germany: Springer-Verlag, 1987; 132-140.
  • 73 Bradley EL, III, Murphy F, Ferguson C. Prediction of pancreatic necrosis by dynamic pancreatography. Ann Surg 1989; 210:495-504.
  • 74 Balthazar EJ, Robinson DL, Megibow AJ, Ranson JHC. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174:331-336.
  • 75 Paulson EK, Vitellas KM, Keogan MT, Low VHS, Nelson RC. Acute pancreatitis complicated by gland necrosis: spectrum of findings on contrast-enhanced CT. AJR Am J Roentgenol 1999; 172:609-613.
  • 76 Johnson CD, Stephens DH, Sarr MG. CT of acute pancreatitis: correlation between lack of contrast enhancement and pancreatic necrosis. AJR Am J Roentgenol 1991; 156:93-95.
  • 77 Vitellas KM, Paulson EK, Enns RA, Keogan MT, Pappas TN. Pancreatitis complicated by gland necrosis: evolution of findings on contrast-enhanced CT. J Comput Assist Tomogr 1999; 23:898-905.
  • 78 Balthazar EJ, Freeny PC, vanSonnenberg E. Imaging and intervention in acute pancreatitis. Radiology 1994; 193:297-306.
  • 79 Basterra G, Alvarez M, Marcaide A, Delgado E, Diaz de Otazu R, Garcia Campos F. Acute pancreatitis: evaluation of the prognostic criteria of the latest Balthazar tomographic classification. Rev Esp Enferm Dig 1999; 91:433-438.
  • 80 van den Biezenbos AR, Kruyt PM, Bosscha K, et al. Added value of CT criteria compared to the clinical SAP score in patients with acute pancreatitis. Abdom Imaging 1998; 23:622-626.
  • 81 Lankisch PG, Wamecke B, Bruns D, et al. The APACHE II score on admission to hospital is unreliable to diagnose necrotizing and thus severe pancreatitis (abstr). Int J Pancreatol 2000; 28:130-131.
  • 82 Lecesne R, Taourel P, Bret PM, Atri M, Reinhold C. Acute pancreatitis: interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome. Radiology 1999; 211:727-735.
  • 83 Morgan DE, Baron TH, Smith JK, Robbin ML, Kenney PJ. Pancreatic fluid collections prior to intervention: evaluation with MR imaging compared with CT and US. Radiology 1997; 203:773-778.
  • 84 Fulcher AS, Turner MA. MR pancreatography: a useful tool for evaluating pancreatic disorders. RadioGraphics 1999; 19:5-24.
  • 85 Semelka RC, Ascher SM. MR imaging of the pancreas. Radiology 1993; 188:593-602.

Article History

Published in print: June 2002